Resilience Appoints Bill Marth as President of Services
National Resilience, Inc. (Resilience), a technology-focused biomanufacturing company dedicated to broadening access to complex medicines, today...
NEWS
Read on
BridgeBio and Resilience Announce Strategic Multi-Year Partnership
Resilience to manufacture BridgeBio’s lead investigational gene therapy treatments, BBP-631 and BBP-812 Partnership provides an innovative, capital...
Resilience Announces Joint Venture with Lifera in Saudi Arabia
The joint venture with Lifera would build an advanced large-scale, commercial drug product manufacturing facility in Riyadh, Saudi Arabia Resilience...
Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity
Financing focused on domestic biomanufacturing capacity and capabilities for biologics, vaccines, and nucleic acids
Resilience Signs Multi-Year Strategic Biomanufacturing Partnership With Leading Pharmaceutical Company
SAN DIEGO--(BUSINESS WIRE)-- National Resilience, Inc. (Resilience), a technology-focused manufacturing company dedicated to broadening access to...
Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates
The facility expands Resilience’s global footprint and represents the first GMP biopharma facility in the region based in the UAE
